Sun Pharma Advanced Research Company Ltd

NSE: SPARC · BSE: 532872 · Pharmaceuticals & Biotechnology · 24 announcements

Share price: ₹197.00
Market cap: ₹6,393 Cr
Revenue (annual): ₹1,879 Cr
Net profit (annual): ₹1,553 Cr
P/E (TTM): 4.0×Sector 47.4×
Promoter holding: 65.67%+0.00% QoQ
FII holding: 3.90%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Other Announcement 3 Financial Results 3 Annual General Meeting 3 Promoter Reclassification 2 Management Change 2 Fund Raise 2 Business Update 2 Board Meeting Date 2 Merger & Restructuring 1 Annual Report 1 Adverse Business Impact 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

2 announcements with these filters

13 Jul 2026 17:37 IST NSE

Management Change

Sun Pharma Advanced Research Company Management Change

SPARC appointed Anil Raghavan as Managing Director and CEO effective August 11, 2026. Dr. Rajamannar Thennati will retire from the Board on August 10, 2026.

Read the filing ↗

26 Jun 2026 18:41 IST BSE

Management Change

Sun Pharma Advanced Research Company Management Change

Sun Pharma Advanced Research Company announced senior management changes. Mr. Prasanna Deshmukh is appointed as Functional Head of HR & Administration.

Read the filing ↗